Efficacy of cyclic and extended regimens of ethinylestradiol 0.02 mg ‐levonorgestrel 0.09 mg for dysmenorrhea: A placebo‐controlled, double‐blind, randomized trial

PURPOSE: We aimed to evaluate the efficacy and safety of 28‐day Cyclic and 84‐day Extended regimens of NPC‐16 (ethinylestradiol 0.02 mg plus levonorgestrel 0.09 mg) in patients with dysmenorrhea. METHODS: This was a placebo‐controlled, double‐blind, randomized trial conducted in Japan. A total of 25...

Descripción completa

Detalles Bibliográficos
Autores principales: Harada, Tasuku, Momoeda, Mikio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022088/
https://www.ncbi.nlm.nih.gov/pubmed/33850455
http://dx.doi.org/10.1002/rmb2.12373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022088/
https://www.ncbi.nlm.nih.gov/pubmed/33850455
http://dx.doi.org/10.1002/rmb2.12373

Ejemplares similares